Who owns BIONDVAX PHARMACEUTICALS LTD?
- Ticker: SCNI
- CUSIP Number: 09073q303
Tip: Access positions for across all investors
Analyze quarterly positions in Biondvax Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biondvax Pharmaceuticals stock
Who bought or sold BIONDVAX PHARMACEUTICALS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 29k | $36k | 147% | Sep 2025 |
|
| Two Sigma Securities | 15k | $19k | 100% | Sep 2025 |
|
| Bank Of Montreal | 10k | $23k | 100% | Jun 2025 |
|
| Rhumbline Advisers | 3.6k | $4.5k | 2% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 1.0k | $1.3k | 100% | Sep 2025 |
|
| Morgan Stanley | 255.00 | $580.915500 | 100% | Jun 2025 |
|
| UBS Group | 8.00 | $10.000000 | -100% | Sep 2025 |
|
Who sold out of Biondvax Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Yorkville Advisors Global | Jun 2025 | 42k | $96k |
| Credit Agricole | Mar 2025 | 42.00 | $113.001000 |